Government
PRODUCTS
-
![GettyImages-1206538208 clinical decsion making]( "Medical Writing: A Collaborative Approach")
Discover how a collaborative approach to medical writing ensures the highest standards of excellence and precision in every document produced.
-
![GettyImages-849207658 Drug toxicity concept]( "NDA Submissions 505(b)(1) Or 505(b)(2)")
There are clearly defined pathways for drug approval, and choosing the right regulatory pathway for your drug development program requires a thorough understanding of sections 505(b)(1) and 505(b)(2) of the Federal Food, Drug, and Cosmetics (FD&C) Act.
-
![Adult woman sits in waiting room-GettyImages-1372189785]( "Support For Clinical Trial Participants")
Clinical trials are how new treatments move from the lab to the people who need them most. By joining a study, you’re not only accessing potential new therapies—you’re helping advance medicine for future generations.
-
![AAV Production]( "Power Your Gene Therapy Pipeline With A Proven AAV CDMO Partner")
With 30+ years of experience in viral vector development and manufacturing, we bring unmatched expertise as your trusted CDMO for AAV. From plasmids to fill/finish and advanced analytics, we provide true end-to-end support, accelerating your path to the clinic and beyond.
-
![cryoport integricell]( "IntegriCell™ Cryopreservation Services From Cryoport Systems")
IntegriCell™ cryopreservation services from Cryoport Systems optimize leukapheresis-derived cell therapies by enhancing the safety, quality, and viability of manufacture-ready cryopreserved leukopaks. Our state-of-the-art cryopreservation process, integrated with our end-to-end global temperature-controlled supply chain platform, provides unmatched reliability, efficiency, and scope. Our standardized protocols meet the highest compliance standards, ensuring consistent quality and addressing product stability issues associated with fresh donor-derived cellular material for an optimized approach that enhances manufacturing efficiency and streamlines operations.
WHITE PAPERS AND CASE STUDIES
-
![Isolated Antibody Drug Conjugates ADCs GettyImages-1438509824]( "The Evolution Of Antibody-Drug Manufacturing")
The Evolution Of Antibody-Drug ManufacturingExplore how ADC chemistry and manufacturing have evolved, the challenges this dynamic growth has created, and how CDMOs are adapting to these changes to meet customer needs, now and in the future.
-
![GettyImages-2181934436-laboratory-analysis-scientists-technology-computer]( "Streamline Analytical Tech Transfer Through Analytical Target Profile")
Streamline Analytical Tech Transfer Through Analytical Target ProfileAnalytics debt in CGT can derail timelines and budgets. Learn how early ATP planning and cross-functional alignment can eliminate costly setbacks and accelerate IND approvals.
-
![1827780686-westminster-CO]( "City Of Westminster, Colorado, And The Value Of Trustworthy Data")
City Of Westminster, Colorado, And The Value Of Trustworthy DataThis case study explores how the City of Westminster in Colorado has implemented a new mobile app, Trimble Unity Mobile for Cityworks, to streamline workflows and reduce manual data entry for water utility crews.
-
![Computer Science Research Laboratory with Robotic Arm Model-GettyImages-968289652]( "ICH E6(R3) In Effect: Transforming Quality Management For CGT Trials")
ICH E6(R3) In Effect: Transforming Quality Management For CGT TrialsDiscover how the updated ICH E6(R3) guideline supports the speed and complexity of CGT manufacturing, enabling flexible, risk‑based decisions and quality systems built to scale therapies safely.
-
![digital key in hand-GettyImages-1312386626]( "Leveraging Life Sciences Data For Intelligent Decision-Making")
Leveraging Life Sciences Data For Intelligent Decision-MakingIndustry 4.0 drives life sciences to prioritize data-driven decision-making by integrating advanced technologies in QMS. Discover how modern data management can improve compliance.
-
![Oncology Cell]( "Radiopharmaceutical Therapy: Global Clinical Trial Insights 2024")
Radiopharmaceutical Therapy: Global Clinical Trial Insights 2024By downloading this report, readers will uncover the transformative potential of radiopharmaceuticals in cancer therapy and stay ahead in the evolving cancer treatment landscape.
-
![AugustBio_Scaling_Fixed]( "Scaling With The Client In Mind: A Customer-Centric Approach To Project Scale-Up")
Scaling With The Client In Mind: A Customer-Centric Approach To Project Scale-UpIn today’s fast-moving biopharma landscape, scaling from clinic to commercial takes more than expertise. See how collaboration can transform scale-up and drive confident progress
-
![GettyImages-2151295139-computer-hands-technology]( "A Toolbox For An Effective Tech Transfer")
A Toolbox For An Effective Tech TransferAs drug development costs rise, companies are embracing digital-first strategies and Pharma 4.0 principles to streamline operations, enhance tech transfer, and accelerate time-to-market through innovation.
-
![GettyImages-1354172647-scientist-in-lab-with-flasks-pipette]( "Clinical Trial Starts Rose At Slower Pace In 2024")
Clinical Trial Starts Rose At Slower Pace In 2024Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.
-
![European flags-GettyImages-139491451]( "Revolution In The EU Pharmaceutical Legislation Ahead")
Revolution In The EU Pharmaceutical Legislation AheadDiscover the impact revised pharmaceutical legislation will have on the industry by superseding regulations that have fostered the availability of safe and effective medicines for the past two decades.
-
![Virtual Compliance Rules, Policies, Regulations GettyImages-1495704742]( "Operationalizing Disclosure Intelligence For Compliance At Scale")
Operationalizing Disclosure Intelligence For Compliance At ScaleLearn how sponsors can transform compliance functions into unique strengths, not only meeting regulatory requirements but also uncovering strategic opportunities in this challenging landscape.
-
![GettyImages-1081869198 data]( "How eSource Reduced Benchmark's Protocol Deviations By Almost 40%")
How eSource Reduced Benchmark's Protocol Deviations By Almost 40%Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.
NEWS
-
Projectmates Awarded Five-Year GSA Schedule Extension1/16/2025
Projectmates, the award-winning construction program management software, is proud to announce a five-year extension of its GSA Schedule contract.
-
Course Charted For Carbon Free Shipping By 20503/25/2025
Fuels of the future and shipping charge points in harbours are at the centre of a major new strategy to make Britain’s shipping fleet net zero by 2050 and drive growth in coastal communities.
-
OFS August Jobs Report: Energy Services Sector Faces Larger Labor Market Headwinds9/8/2025
Today, the Energy Workforce & Technology Council released its August 2025 jobs report, suggesting continued labor market softening across both the energy services sector and the broader U.S. economy.
-
Latvian Scientists Create A Tool For More Efficient Public Procurement Evaluation1/10/2026
Much of public procurement evaluation consists of manual work by experts and specialists. This is time-consuming, since it involves comparing extensive documentation, evaluating compliance with regulatory requirements—like whether there are competition-restricting criteria—and other factors.
-
City Of West Haven, CT, Modernizes Procurement With OpenGov2/28/2025
Relying on paper-based processes and limited vendor engagement, West Haven leadership needed a modern solution to increase competition and streamline procurement.